Concepedia

J Speyer

JS

Statistics

Publications

4

Citations

192

H-Index

4

Active since

1985

Affiliations

New York University(Current)

J Speyer is an author at New York University specializing in oncology, pharmacology, and chemotherapy.

Publications per year

1985–2006

4

Publications

4

Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity.

Carolyn Wasserheit, Andrea Frazein, Ruth Oratz et al. · Journal of Clinical Oncology · 1996 · 87 citations

Medicine, Oncology, Pharmacology +15

4'Epidoxorubicin (epirubicin): activity in hepatocellular carcinoma.

Howard S. Höchster, M D Green, J Speyer et al. · Journal of Clinical Oncology · 1985 · 83 citations

Pharmacy, Oncology, Pharmacology +16

Report of first-stage accrual for NCI 5886, a phase II study of erlotinib, carboplatin and paclitaxel as first-line treatment of ovarian cancer

Stephanie V. Blank, John P. Curtin, Noah A. Goldman et al. · Journal of Clinical Oncology · 2006 · 12 citations

Medicine, Oncology, Pharmacology +17

A phase II Trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody in subjects with heavily treated and platinum-resistant advanced Müllerian malignancies

Michael V. Seiden, H. A. Burris, U. Matulonis et al. · Journal of Clinical Oncology · 2005 · 10 citations

Medicine, Oncology, Pharmacology +15

1–4 of 4